This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Western University of Health Sciences. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Jinghua Jeffrey Wang in Cancer Therapy
Introduction
Jinghua Jeffrey Wang is an accomplished inventor based in Arcadia, CA (US). He has made significant contributions to the field of cancer therapy through his innovative research and inventions. His work focuses on overcoming drug resistance in cancer treatment, which is a critical challenge in oncology.
Latest Patents
Jinghua Jeffrey Wang holds 1 patent related to his groundbreaking invention. This patent provides extracts and compositions derived from organic solvent extracts aimed at overcoming drug resistance in cancer therapy. The invention details methods of treating cancer by administering a combination of an organic solvent extract and a chemotherapeutic drug. This approach is particularly beneficial for cancers that have shown resistance to traditional chemotherapeutic treatments.
Career Highlights
Wang is affiliated with the Western University of Health Sciences, where he continues to advance his research in cancer treatment. His dedication to improving therapeutic outcomes for cancer patients is evident in his innovative approaches and methodologies.
Collaborations
Throughout his career, Jinghua Jeffrey Wang has collaborated with notable colleagues, including Moses Sing Sum Chow and Ying Huang. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Jinghua Jeffrey Wang's contributions to cancer therapy through his innovative patent highlight the importance of addressing drug resistance in treatment. His work exemplifies the potential of research and innovation in improving patient outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
